• 1.

    Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96 https://doi.org/10.3322/caac.21456.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 2.

    Mitra R, Chen X, Greenawalt EJ, Maulik U, Jiang W, Zhao Z, et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun. 2017;8(1):1604.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. The Lancet Oncology. 2014;15(1):23–34 10.1016/S1470-2045(13)70546-1.

    PubMed 

    Google Scholar
     

  • 4.

    Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–32.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 6.

    Corrado G, Salutari V, Palluzzi E, Distefano MG, Scambia G, Ferrandina G. Optimizing treatment in recurrent epithelial ovarian cancer. Expert Rev Anticancer Ther. 2017;17(12):1147–58.

    CAS 
    PubMed 

    Google Scholar
     

  • 7.

    Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, et al. Ovarian Cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(2):191–226.

    CAS 

    Google Scholar
     

  • 8.

    Dinger ME, Pang KC, Mercer TR, Mattick JS. Differentiating protein-coding and noncoding RNA: challenges and ambiguities. PLoS Comput Biol. 2008;4(11):e1000176.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 9.

    Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–325.

    CAS 
    PubMed 

    Google Scholar
     

  • 10.

    Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.

    CAS 
    PubMed 

    Google Scholar
     

  • 11.

    Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 2018;37(30):4094–109.

    CAS 
    PubMed 

    Google Scholar
     

  • 12.

    Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 13.

    Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 14.

    Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71(20):6320–6.

    CAS 
    PubMed 

    Google Scholar
     

  • 15.

    Wang W, He X, Zheng Z, Ma X, Hu X, Wu D, et al. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Mol Cancer. 2017;16(1):75.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 16.

    Liang H, Zhao X, Wang C, Sun J, Chen Y, Wang G, et al. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer. Mol Cancer. 2018;17(1):96.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 17.

    Wang C, Wang J, Shen X, Li M, Yue Y, Cheng X, et al. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. J Exp Clin Cancer Res. 2021;40(1):101.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 18.

    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

    CAS 
    PubMed 

    Google Scholar
     

  • 19.

    Chen D, Lu T, Tan J, Li H, Wang Q, Wei L. Long non-coding RNAs as communicators and mediators between the tumor microenvironment and Cancer cells. Front Oncol. 2019;9:739.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 20.

    Zhang Y, Mao Q, Xia Q, Cheng J, Huang Z, Li Y, et al. Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers. J Hematol Oncol. 2021;14(1):169.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 21.

    Varier KM, Dhandapani H, Liu W, Song J, Wang C, Hu A, et al. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells. J Exp Clin Cancer Res. 2021;40(1):242.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 22.

    Shang A, Wang W, Gu C, Chen C, Zeng B, Yang Y, et al. Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. J Exp Clin Cancer Res. 2019;38(1):411.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 23.

    Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321–30.

    CAS 
    PubMed 

    Google Scholar
     

  • 24.

    Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.

    PubMed 

    Google Scholar
     

  • 25.

    Ozes AR, Miller DF, Ozes ON, Fang F, Liu Y, Matei D, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35(41):5350–61.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 26.

    Jiang Y, Wang C, Zhou S. Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochim Biophys Acta Rev Cancer. 1873;2020(2):188361.


    Google Scholar
     

  • 27.

    Matei D, Nephew KP. Epigenetic attire in ovarian Cancer: the Emperor’s new clothes. Cancer Res. 2020;80(18):3775–85.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 28.

    Wu DD, Chen X, Sun KX, Wang LL, Chen S, Zhao Y. Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC. Mol Cancer. 2017;16(1):138.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Huang D, Chen J, Yang L, Ouyang Q, Li J, Lao L, et al. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. 2018;19(10):1112–25.

    CAS 
    PubMed 

    Google Scholar
     

  • 30.

    Li JP, Li R, Liu X, Huo C, Liu TT, Yao J, et al. A seven immune-related lncRNAs model to increase the predicted value of lung adenocarcinoma. Front Oncol. 2020;10:560779.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 31.

    Chen P, Gao Y, Ouyang S, Wei L, Zhou M, You H, et al. A prognostic model based on immune-related long non-coding RNAs for patients with cervical Cancer. Front Pharmacol. 2020;11:585255.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 32.

    Ma W, Zhao F, Yu X, Guan S, Suo H, Tao Z, et al. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. J Transl Med. 2020;18(1):442.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 33.

    Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol. 2020;31(9):1240–50.

    CAS 
    PubMed 

    Google Scholar
     

  • 34.

    Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, et al. Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun. 2018;9(1):4319.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 35.

    Huang B, Song JH, Cheng Y, Abraham JM, Ibrahim S, Sun Z, et al. Long non-coding antisense RNA KRT7-AS is activated in gastric cancers and supports cancer cell progression by increasing KRT7 expression. Oncogene. 2016;35(37):4927–36.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 36.

    Chen F, Chen Z, Guan T, Zhou Y, Ge L, Zhang H, et al. N(6) -Methyladenosine regulates mRNA stability and translation efficiency of KRT7 to promote breast Cancer lung metastasis. Cancer Res. 2021;81(11):2847–60.

    PubMed 

    Google Scholar
     

  • 37.

    Chen S, Su T, Zhang Y, Lee A, He J, Ge Q, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes. 2020;11(3):511–25.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 38.

    An Q, Liu T, Wang MY, Yang YJ, Zhang ZD, Liu ZJ, et al. KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGFbeta/Smad2/3 signaling pathway. Oncol Rep. 2021;45(2):481–92.

    CAS 
    PubMed 

    Google Scholar
     

  • 39.

    Liang JR, Martinez A, Lane JD, Mayor U, Clague MJ, Urbe S. USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. EMBO Rep. 2015;16(5):618–27.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 40.

    Gao M, Wang X, Han D, Lu E, Zhang J, Zhang C, et al. A six-lncRNA signature for Immunophenotype prediction of Glioblastoma Multiforme. Front Genet. 2020;11:604655.

    CAS 
    PubMed 

    Google Scholar
     

  • 41.

    Wan J, Guo C, Fang H, Xu Z, Hu Y, Luo Y. Autophagy-related long non-coding RNA is a prognostic Indicator for bladder Cancer. Front Oncol. 2021;11:647236.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 42.

    Zhang H, Hua Y, Jiang Z, Yue J, Shi M, Zhen X, et al. Cancer-associated fibroblast-promoted LncRNA DNM3OS confers Radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. 2019;25(6):1989–2000.

    CAS 
    PubMed 

    Google Scholar
     

  • 43.

    Yin X, Yin Y, Dai L, Shen C, Chen N, Li J, et al. Integrated analysis of long non-coding RNAs and mRNAs associated with malignant transformation of gastrointestinal stromal tumors. Cell Death Dis. 2021;12(7):669.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 44.

    Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, et al. Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis. Cancer Lett. 2021;503:19–31.

    CAS 
    PubMed 

    Google Scholar
     

  • 45.

    Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–22.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 46.

    DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–82.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)